Perhaps we will find a supportive partner(s) for Alzheimer's distribution world wide and then in a few years a possible merger.
Our tech seems the be the most advanced in fighting the epigenetic source of many diseases. If successful ( as I expect) then it will destroy the product line and market cap of several Big Pharmas. They would be wise to partner in some fashion.
I don't see a buy out of any sort in the next few years.